Dysregulation of Wnt-beta-catenin signaling disrupts axis formation in vert
ebrate embryos and underlies multiple human malignancies. The adenomatous p
olyposis coli (APC) protein, axin, and glycogen synthase kinase 3 beta form
a Wnt-regulated signaling complex that mediates the phosphorylation-depend
ent degradation of beta-catenin. A protein phosphatase 2A (PP2A) regulatory
subunit, B56, interacted with APC in the yeast two-hybrid system. Expressi
on of B56 reduced the abundance of beta-catenin and inhibited transcription
of beta-catenin target genes in mammalian cells and Xenopus embryo explant
s. The B56-dependent decrease in beta-catenin was blocked by oncogenic muta
tions in beta-catenin or APC, and by proteasome inhibitors. B56 may direct
PP2A to dephosphorylate specific components of the APC-dependent signaling
complex and thereby inhibit Wnt signaling.